These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20661217)

  • 1. The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells.
    Goncharenko-Khaider N; Lane D; Matte I; Rancourt C; Piché A
    Oncogene; 2010 Oct; 29(40):5523-36. PubMed ID: 20661217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.
    Li SS; Yang S; Wang S; Yang XM; Tang QL; Wang SH
    Oncol Rep; 2011 Dec; 26(6):1573-9. PubMed ID: 21850380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells.
    Lane D; Robert V; Grondin R; Rancourt C; Piché A
    Int J Cancer; 2007 Sep; 121(6):1227-37. PubMed ID: 17534891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
    Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of mesothelioma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by heat stress via the inhibition of the 3-phosphoinositide-dependent kinase 1/Akt pathway.
    Pespeni MH; Hodnett M; Abayasiriwardana KS; Roux J; Howard M; Broaddus VC; Pittet JF
    Cancer Res; 2007 Mar; 67(6):2865-71. PubMed ID: 17363610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.
    Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S
    Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Peuhu E; Rivero-Müller A; Stykki H; Torvaldson E; Holmbom T; Eklund P; Unkila M; Sjöholm R; Eriksson JE
    Oncogene; 2010 Feb; 29(6):898-908. PubMed ID: 19935713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand.
    Li LC; Jayarama S; Pilli T; Qian L; Pacini F; Prabhakar BS
    Thyroid; 2013 Jan; 23(1):70-8. PubMed ID: 22998497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Rychahou PG; Murillo CA; Evers BM
    Surgery; 2005 Aug; 138(2):391-7. PubMed ID: 16153452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3.
    Choi WY; Jin CY; Han MH; Kim GY; Kim ND; Lee WH; Kim SK; Choi YH
    Anticancer Res; 2009 Nov; 29(11):4457-65. PubMed ID: 20032392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic induction of TRAIL-mediated apoptosis by anisomycin in human hepatoma cells via the BH3-only protein Bid and c-Jun/AP-1 signaling pathway.
    Jin CY; Park C; Hong SH; Han MH; Jeong JW; Xu H; Liu H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):321-8. PubMed ID: 23582782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53.
    Shankar E; Sivaprasad U; Basu A
    Oncogene; 2008 Jun; 27(28):3957-66. PubMed ID: 18317451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells.
    Dida F; Li Y; Iwao A; Deguchi T; Azuma E; Komada Y
    Exp Hematol; 2008 Oct; 36(10):1343-53. PubMed ID: 18599181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneously targeting Bcl-2 and Akt pathways reverses resistance of nasopharyngeal carcinoma to TRAIL synergistically.
    Li SS; Tang QL; Wang SH; Chen YH; Liu JJ; Yang XM
    Tumori; 2011; 97(6):762-70. PubMed ID: 22322844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of FLIP(S) by Akt, a possible inhibition mechanism of TRAIL-induced apoptosis in human gastric cancers.
    Nam SY; Jung GA; Hur GC; Chung HY; Kim WH; Seol DW; Lee BL
    Cancer Sci; 2003 Dec; 94(12):1066-73. PubMed ID: 14662022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell detachment modulates TRAIL resistance in ovarian cancer cells by downregulating the phosphatidylinositol 3-kinase/Akt pathway.
    Lane D; Cartier A; Rancourt C; Piché A
    Int J Gynecol Cancer; 2008; 18(4):670-6. PubMed ID: 17868340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism.
    Lincoln FA; Imig D; Boccellato C; Juric V; Noonan J; Kontermann RE; Allgöwer F; Murphy BM; Rehm M
    Cell Death Dis; 2018 Nov; 9(11):1112. PubMed ID: 30385739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis.
    Ryu BJ; Hwang MK; Park M; Lee K; Kim SH
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3862-5. PubMed ID: 22622069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.